Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by HuntNGatheron Feb 11, 2014 12:35pm
250 Views
Post# 22195945

Stem Cell Therapeutics Corp is the RIGHT name

Stem Cell Therapeutics Corp is the RIGHT nameGlad that we have been holding our ground well over the last while. Not sure of the veracity of the comments from the session yesterday but IF there was any mention made of changing the name, I would have to object. Cancer Stem Cells is what we do now. From the very beginning, that clear and unambiguous but still broadly applicable name that we carry is extremely valuable. Despite the confusion with Stem Cells Inc. which can be cleared up fairly quickly, it allows someone to know right away what playground we play in. Changing it to something more traditionally pharma/marketing that sounds pleasant but says nothing would be a mistake in my view. My vote would be to keep the name and keep the focus to crush some of these opportunities ahead of us. That way, when people get news of SCT success, there is no confusion. Although perhaps Stem Cell Inc will want to share in the glow...
Bullboard Posts